Praziquantel tablets are indicated in patients aged 1 year and older for the treatment of the following infections: Schistosomiasis due to all species of schistosoma (for example, Schistosoma mekongi, Schistosoma japonicum, Schistosoma mansoni and Schistosoma hematobium ), and Clonorchiasis and Opisthorchiasis due to the liver flukes…
From the U.S. FDA-approved label for Praziquantel. Full label: DailyMed.
Praziquantel tablets are indicated in patients aged 1 year and older for the treatment of the following infections: Schistosomiasis due to all species of schistosoma (for example, Schistosoma mekongi, Schistosoma japonicum, Schistosoma mansoni and Schistosoma hematobium ), and Clonorchiasis and Opisthorchiasis due to the liver flukes, Clonorchis sinensis/Opisthorchis viverrini (approval of this indication was based on studies in which the two species were not differentiated) Praziquantel tablets are an anthelmintic indicated in patients aged one year and older for the treatment of the following infections: Schistosomiasis due to all species of schistosoma (for example, Schistosoma mekongi, Schistosoma japonicum, Schistosoma mansoni and Schistosoma hematobium ), and, Clonorchiasis and Opisthorchiasis due to the liver flukes, Clonorchis sinensis and Opisthorchis viverrini.
From the U.S. FDA-approved label for Praziquantel. Full label: DailyMed.
Schistosomiasis: 20 mg/kg body weight 3 times a day separated by 4 to 6 hours for 1 day only. Clonorchiasis and Opisthorchiasis: 25 mg/kg 3 times a day separated by 4 to 6 hours for 1 day only. Take with water during meals.
Directions from the U.S. FDA-approved label for Praziquantel — your doctor or pharmacist may advise differently.
Praziquantel is contraindicated in: Patients who previously have shown hypersensitivity to praziquantel or any of the excipients in praziquantel tablets. Patients with ocular cysticercosis; since parasite destruction within the eye that occurs because of hypersensitivity reaction to the dead parasite after treatment may cause irreversible lesions, ocular cysticercosis must not be treated with praziquantel. Patients taking strong Cytochrome P450 3A enzyme (CYP 3A) inducers, such as rifampin. Known hypersensitivity to praziquantel or any of its ingredients.
Excerpt from the U.S. FDA-approved label for Praziquantel. Talk to a pharmacist or doctor before use.
Clinical Deterioration: Potentially life threatening clinical deterioration can occur in patients treated during the acute phase of schistosomiasis. Central Nervous System (CNS) Effects: Praziquantel can exacerbate central nervous system pathology due to schistosomiasis. Consider whether to administer to individuals reporting a history of epilepsy and/or other signs of potential central nervous systems involvement such as subcutaneous nodules suggestive of cysticercosis. Potential Lack of Efficacy for Acute Schistosomiasis: This has been reported in observational studies.
Warnings and precautions excerpt from the U.S. FDA-approved label for Praziquantel — not a complete list. Talk to a pharmacist or doctor before use.
The following serious or otherwise important adverse reactions are discussed elsewhere in the labeling: Clinical Deterioration Central Nervous System (CNS) Effects Potential Lack of Efficacy During the Acute Phase of Schistosomiasis Cardiac Arrhythmias Hepatic Impairment in Hepatosplenic Schistosomiasis Patients Concomitant Administration with Strong Cytochrome P450 Inducers The following adverse reactions associated with the…
Excerpt from the U.S. FDA-approved label for Praziquantel — not a complete list. Talk to a pharmacist or doctor about side effects.
Store at 20 ° to 25 ° C (68 ° to 77 ° F);
Storage information from the U.S. FDA-approved label for Praziquantel.
What is Taenicid?
Taenicid 600mg Tablet is a Praziquantel medicine made by Deurali Janta Pharmaceuticals Pvt. Ltd. It comes as 600mg Tablet.
What is the generic name of Taenicid?
The generic name of Taenicid is Praziquantel.
What are the side effects of Praziquantel?
The following serious or otherwise important adverse reactions are discussed elsewhere in the labeling: Clinical Deterioration Central Nervous System (CNS) Effects Potential Lack of Efficacy During the Acute Phase of Schistosomiasis Cardiac Arrhythmias Hepatic Impairment in Hepatosplenic Schistosomiasis Patients Concomitant Administration with Strong Cytochrome P450 Inducers The following adverse reactions associated with the…
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
Every NepalDoc section, one tap away.
Find doctors by specialty across Nepal.